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In interleukin-23 (IL-23)-dependent colitis, there is
excessive accumulation of short-lived neutrophils
and inflammatory monocytes in the intestine. It is
unknown whether this reflects changes in mature
cell populations or whether the IL-23-driven colito-
genic T cell program regulates upstream hematopoi-
etic stem and progenitor cells (HSPC). Here we have
shown dysregulation of hematopoiesis in colitis
mediated by inflammatory cytokines. First, there
was an interferon-gamma-dependent accumulation
of proliferating hematopoietic stem cells in the
bonemarrow and spleen. Second, there was a strong
skew toward granulocyte-monocyte progenitor
(GMP) production at the expense of erythroid and
lymphoid progenitors. Extramedullary hematopoi-
esis was also evident, and granulocyte macro-
phage-colony stimulating factor (GM-CSF) blockade
reduced the accumulation of splenic and colonic
GMPs, resulting in amelioration of colitis. Impor-
tantly, transfer of GMPs exacerbated colitis. These
data identify HSPCs as a major target of the IL-23-
driven inflammatory axis suggesting therapeutic
strategies for the treatment of inflammatory bowel
disease.
INTRODUCTION
Dysregulated interleukin-23 (IL-23)-dependent responses have
been shown to mediate experimental colitis in mice and have
been linked to inflammatory bowel disease (IBD) in humans
(Izcue et al., 2009). Recent evidence suggests that IL-23 acts
as a molecular switch to promote pathological STAT3 and
RORgt transcription factor-dependent T cell and innate
lymphoid cell (ILC) responses (Ahern et al., 2010; Buonocore
et al., 2010). Both T cell and ILC-driven colitis are characterized
by marked accumulation of myeloid cells in the colon, particu-
larly neutrophils and inflammatory monocytes (Griseri et al.,1116 Immunity 37, 1116–1129, December 14, 2012 ª2012 Elsevier In2010; Maloy et al., 2003; Erdman et al., 2009). Despite strong
evidence of the pathophysiological role of IL-23 in colitis, little
is known about the key downstream colitogenic mechanisms,
particularly the link to increased myeloid cell responses.
Upon activation, neutrophils can release a plethora of inflam-
matory products (e.g., tumor necrosis factor [TNF], chemokines,
proteases, and reactive oxygen species), and their excessive
accumulation causes tissue damage in chronic inflammatory
diseases (Nathan, 2006). In IBD patients, accumulation of tissue
toxic neutrophils in the inflamed tissue correlates with clinical
disease activity (Chin and Parkos, 2006) and the amount of fecal
calprotectin (a predominant component of the neutrophil
cytosol) is a clinical marker in IBD (Foell et al., 2009). In addition,
high numbers of inflammatory monocytes and macrophages are
present in the inflamed intestine in Crohn’s disease patients
(Kamada et al., 2008). To date, most therapeutic strategies in
IBD have focused on targeting effector T cells. By contrast, the
regulation of innate cell accumulation in the inflamed intestinal
mucosa is poorly understood, particularly how inflammatory
myeloid cells are regulated at their site of production, the bone
marrow (BM). Chronic and sustained accumulation of myeloid
cells places substantial pressure on granulomonocytopoiesis
in the BM. Indeed, innate cells, especially neutrophils, have a
very short life span compared to long-lived T and B cells, and
tight regulation between supply from the BM and demand in
the periphery is essential. However, the regulation of the
upstream and primordial hematopoietic stem and progenitor
cells (HSPCs) during colitis and other chronic inflammatory
diseases is poorly characterized.
The development of HSPCs at steady state follows a hierarchy
tightly regulated by endogenous signals, and the diverse steps of
this developmental pathway can be precisely identified by flow
cytometry, from the multipotent and self-renewing long-term
hematopoietic stem cells (LT-HSCs) to the downstream and
highly proliferative lineage-committed progenitors, e.g., the
granulocyte-monocyte progenitors (GMPs) (see Figure S1A
available online) (Kondo et al., 2003). Recent studies have shown
that HSPCs are far more sensitive to exogenous environmental
cues than previously anticipated, due in part to the expression
of receptors for various microbial products and inflammatory
cytokines, such as toll-like receptors (TLRs) and receptors to
type I and type II interferons (IFNs) (Baldridge et al., 2010; Nagaic.
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Figure 1. Differential Regulation of Hematopoietic Lineages in Colitis
Colitis was induced by transfer of naive CD4+CD45RBhi T cells into C57BL/6.Rag1/ mice. Colitic mice were killed 8 wk after transfer (termed colitic) and
compared with untransferred Rag1/ mice (termed control).
(A) Total cell numbers in spleen, bone marrow (one leg, femur and tibia), MLN, and colon (colonic lamina propria leukoctyes, cLPL) (±SEM, n = 5 mice per group).
(B) Representative flow cytometry staining of neutrophils (CD11b+Gr1hiSSChi) and inflammatory monocytes (CD11b+Gr1intSSClo) from spleen, MLN, and colon
(cLPL) cell suspensions.
(C) Representative staining of neutrophils, monocytes, NK cells (NKp46+), erythroid cells (Ter119+), and immature B cells (B220int) from bone marrow cell
suspensions.
(D) Representative Gr1, Ter119, and NKp46 staining from spleen cell suspensions. Data are representative of three independent experiments.
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Dysregulated Hematopoiesis Promotes Colitiset al., 2006; Takizawa et al., 2012). Despite our knowledge of the
developmental process during the steady state, little is known
about the hematopoietic control mechanisms during acute infec-
tion and even less in chronic inflammatory conditions (Takizawa
et al., 2012).
Here we have asked how HSCs and progenitor cells are
regulated during intestinal inflammation to determine whether
they contribute to the pathophysiological network that drives
colitis. Our results provide the evidence that HSC activity is
dramatically modified during intestinal inflammation. There
was a marked increase in HSC proliferation, and these cells
accumulated not only in the BM of colitic mice but also at extra-
medullary sites. This was accompanied by a substantial skewing
of HSC differentiation toward GMPs, which were increased in
the BM as well as the inflamed spleen and colon. The inflamma-
tory cytokines IFN-g and GM-CSF promoted dysregulated
hematopoiesis acting at distinct points in stem and progenitor
cell differentiation. Furthermore adoptive transfer of splenic
GMPs led to aggravation of colitis, providing a direct link to
disease pathogenesis.ImmRESULTS
Differential Regulation of Hematopoietic Lineages
in Colitis
To investigate the link between IL-23-driven pathogenic T cell
responses and myeloid cell accumulation in colitis, we used a
T cell transfer model that resembles aspects of IBD in humans.
In this model, Rag1/ mice transferred with naive CD4+
CD25CD45RBhi T cells develop wasting disease and colitis
(Powrie et al., 1994) with splenomegaly, mesenteric lymph
node (MLN) enlargement, and severe leukocytic infiltration of
the colon (Figure 1A). In addition to accumulation of colitogenic
T helper-1 (Th1) and Th17 cells (Griseri et al., 2010; Ahern
et al., 2010), there was a marked increase of neutrophils
(CD11b+Gr1hiSSChi) and inflammatory monocytes (CD11b+
Gr1intSSClo) in the spleen, MLN, and colon 2 months after
T cell transfer (Figure 1B). Analysis of mature cells of different
lineages in the BM showed a similar increase in monocytes
and neutrophils accompanying intestinal inflammation (Fig-
ure 1C). In parallel, the percentages of both lymphoid andunity 37, 1116–1129, December 14, 2012 ª2012 Elsevier Inc. 1117
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Dysregulated Hematopoiesis Promotes Colitiserythroid populations, including natural killer (NK) cells, imma-
ture B cells (B220int), and Ter119+ erythroid cells, were reduced
in the BM of colitic mice compared to controls (Figure 1C). These
hematopoietic lineage changes in the BM were reflected in
reduced percentages of NK cells and erythroid cells in the spleen
of colitic mice and a considerable expansion of Gr1+ cells
(Figure 1D).
Increase in Proliferative HSC in the BM of Colitic Mice
As we observed substantial qualitative changes in mature cell
composition within the BM, we next investigated whether the
upstream HSPCs were affected by intestinal inflammation.
Mature cell changes in the BM could be the result of modifica-
tions in proliferation of immature and precursor cells (lineage
positive) or survival of mature cells with only a modest con-
tribution from the stem and progenitor compartment. On the
other hand, an uncontrolled increase of clonogenic HSPCs
could have considerable repercussions on the severity and chro-
nicity of intestinal inflammation. HSPCs reside in the IL-7R
and IL-7R+ lineage (Lin) negative compartment (CD3CD4
CD8CD11bCD11cGr1Ter119B220NKp46FcεRI) that
represents 2% of total BM cells (Figure 2D, left panel). Hema-
topoietic stem cells (HSCs) are rare cells, representing only
0.01% of total BM cells, but are highly enriched among
LinSca1+c-Kithi cells, designated as LSKs ([Kondo et al.,
2003]; see Figure S1A). The inflammatory environment associ-
ated with colitis led to a 5.7-fold increase in the percentage of
LSKs among Lin cells in the BM compared to control mice (Fig-
ure 2A) with a doubling in the percentage of proliferating LSKs
(Ki-67+, Figure 2A).
LT-HSCs, the only life-long self-renewing HSCs, are enriched
among CD34LSK cells [(Osawa et al., 1996) and (Figure S1A)].
On average, 20% of LT-HSCs were cycling at steady state,
whereas this number reached 50% during colitis, correlating
with an 8-fold increase in the absolute number of LT-HSC in
the BMof colitic mice (Figure 2B). Notably, protection from colitis
by cotransfer of regulatory T cells (Treg cells), which are enriched
among CD4+ T cells in the BM (Griseri et al., 2010), prevented
the HSC expansion (Figures 2A and 2B). The use of the SLAM
molecule CD150 as an additional marker for LT-HSCs (Kiel
et al., 2005) confirmed the marked increase of LT-HSCs during
intestinal inflammation (Figure S1B). Overall, HSC proliferation
was increased in the BM of colitic mice, and LT-HSC accumula-
tion was particularly striking, showing that the inflammation
associated with colitis had a substantial impact on the most
primordial steps of hematopoiesis.
Intestinal Inflammation Skews HSC Differentiation
toward GMPs
HSCs give rise to multipotent progenitors (MPPs) that have lost
self-renewal capacity and will later differentiate into highly prolif-
erative lineage-committed progenitors: either commonmyeloer-
ythroid progenitors (CMPs) or common lymphoid progenitors
(CLPs) (Kondo et al., 2003). CMPs will segregate into either
megakaryocyte-erythroid progenitors (MEPs) or granulocyte-
monocyte progenitors (GMPs) (Akashi et al., 2000; see Fig-
ure S1A for definitions). During colitis, the cell composition inside
the myeloid progenitor population (MP, LinSca-1c-Kithi)
changed considerably. Thus the percentage of GMPs among1118 Immunity 37, 1116–1129, December 14, 2012 ª2012 Elsevier InMPs increased from 19% to 46% with a 3.9-fold change in total
number in colitic mice (Figure 2C). This GMP increase, which
was not observed in Treg cell protected mice, was mirrored by
a substantial decrease in MEPs in the BM of colitic mice (Fig-
ure 2C, left panel). Lymphoid progenitors are Lin IL-7R+,
whereas MPs are IL-7R (Kondo et al., 2003). During colitis,
LinIL-7R+ cell frequency among Lin cells was reduced (Fig-
ure 2D) and the percentage of CLPs (LinIL-7R+Sca-1intc-Kitint)
was significantly decreased compared to control mice (Fig-
ure 2D). Collectively, the progenitor composition inside the BM
was dramatically altered during intestinal inflammation with
a skew toward GMP differentiation, at the expense of both
MEP and CLP differentiation.
A decrease in lymphoid cells was not restricted to Rag1/
hosts because lymphoid cell production in the BM was also
decreased in a lymphocyte-replete model of colitis in which
WT mice infected with Helicobacter hepaticus develop
intestinal inflammation in the absence of IL-10 signaling
(Kullberg et al., 2006). The large population of B cells (B220+)
present in the BM of WT controls was considerably reduced
during colitis as were erythroid cells (Figure S2A), in contrast
with increases of Gr1+ myeloid cells in BM and spleen (Figures
S2A and S2B). These mature cell changes also correlated with
a significant increase of GMPs and decrease of MEPs and
CLPs in the BM of lymphocyte-replete colitic mice (Figures
S2C and S2D).
Accumulation of HSCs and GMPs in the Spleen
of Colitic Mice
The low basal migration of HSCs from the BM to the periphery
is a well-established phenomenon, but its functional relevance
is unknown (Kondo et al., 2003). However, peripheral HSCs
may contribute to emergency extramedullary hematopoiesis
within infected tissues (Massberg et al., 2007). The rare popula-
tion of HSCs in the blood and spleen resembles marrow HSCs
because they are capable of long-term multilineage reconstitu-
tion after transfer into irradiated hosts (Bhattacharya et al.,
2009; Morita et al., 2010). In the spleen of colitic mice, the
percentage of proliferating LSKs was significantly higher than
in controls, accompanied by a substantial accumulation of
splenic LSKs (Figure 3A). In addition, the CD150+ population of
LT-HSC that was very rare in the spleen of control mice was
readily detectable in colitic mice (Figure S1B). Similarly, GMPs
that were barely detectable in the spleen at steady state (Fig-
ure 3B) were significantly increased during colitis (4.9-fold in
percentage and 20-fold in absolute number), whereas Treg cell
protected mice showed only a modest GMP increase compared
to controls (Figure 3B).
To determine the functional role of these changes, we
assessed hematopoietic activity by quantifying colony forming
units (cfu). In the spleen, the cfu-granulocyte and macrophage
(cfu-GM) activity per cell was significantly increased in colitic
mice compared to controls (Figure 3C). Because GMPs and
mobilized HSCs have high proliferative indexes (Passegue´
et al., 2005), their accumulation in the inflamed spleen consti-
tutes a reservoir of HSPCs capable of engaging in extramedul-
lary hematopoiesis, which may contribute substantially to the
increase of peripheral neutrophils and monocytes that promotes
intestinal inflammation.c.
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Figure 2. Increase in Proliferative HSCs in the Bone Marrow of Colitic Mice and Skewed Differentiation toward GMPs
Rag1/ mice received either naive T cells alone (termed colitic) or in combination with CD4+CD25+ Treg cells (termed protected) or were untreated (termed
control). Transferred mice were killed 8 wk after transfer. BM cells were stained for HSPCs (see Figure S1 for population FACS-definitions).
(A) Representative flow cytometry staining and percentages of LSKs (LinSca-1+c-Kithi cells, highly enriched for HSC) among BM Lin cells. In some experi-
ments, BM cells were stained for the proliferative marker Ki-67 (right panel).
(B) Percentages, absolute numbers, and proliferation of LT-HSCs (CD34LSKs) in the BM.
(C) Representative flow cytometry staining of CMP, GMP, and MEP population in the BM (left). Absolute numbers of GMPs (right) and percentages among
LinSca-1c-Kithi MP cells (middle).
(D) Flow cytometry staining of IL-7R expression among Lincells in the BM (left) and c-Kit and Sca-1 expression among LinIL-7R+ cells (middle). Percentages of
CLP (LinIL-7R+Sca-1intc-Kitint) among Lin cells (right).
Numbers in dot plots indicate percentages among gated cells. Each point represents an individual mouse and horizontal bars represent groupmeans (A–D). Data
are representative of three independent experiments. Error bars represent SEM.
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Figure 3. Accumulation of HSC and GMP in the Spleen of Colitic Mice
Rag1/ mice received either naive T cells alone (colitic) or in combination with Treg cells (protected) or were untreated (control). Transferred mice were killed
8 wk after transfer.
(A) Representative flow cytometry staining, percentages, absolute numbers, and proliferation (Ki-67) of LSK cells in the spleen.
(B) Flow cytometry staining of splenic CMPs, GMPs, and MEPs. Percentages (middle) and numbers of splenic GMP (right).
(C) Cfu activity. Frequency of clonogenic cfu-GM (cfu-granulocyte and macrophage) among total splenocytes. Data are representative of three independent
experiments. Error bars represent SEM.
Immunity
Dysregulated Hematopoiesis Promotes ColitisGMPs Accumulate in the Inflamed Intestinal Mucosa
and Trigger Extramedullary Hematopoiesis
Because the colonic increase of neutrophils and monocytes is
extensive and sustained over the course of colitis (Figures 1A
and 1B), we investigated whether peripheral HSPC activity could
be detected in the inflamed intestinal mucosa. Colonic GMPs
were barely detectable at steady state, but their frequency was
markedly increased in colitis (Figure 4A) with an accompanying
13.5-fold rise in absolute number compared to controls (Fig-
ure 4A). GMPs also emerged in the inflamed MLN (Figure S3A).
It is important to note that, as previously described in BM and
spleen (Passegue´ et al., 2005), the GMP population was highly
proliferative in the colon (Figure 4B) and therefore had the poten-
tial to generate neutrophils and monocytes directly inside the in-
flamed tissue. Consistent with this, the amounts of messenger
RNA (mRNA) for granulocyte-colony stimulating factor (G-CSF)
and granulocyte and macrophage colony stimulating factor
(GM-CSF) (the key colony stimulating factors [CSF] that regulate
granulocyte andmonocyte progenitors) were increased in the in-
flamed colon and therefore capable of sustaining proliferation of
colonic GMPs (Figure 4C).
Functionally, the phenotypic changes in progenitors in the
inflamed colon correlated with striking modifications in hemato-
poietic activity. Indeed, cfu-GM activity per cell, which was very
low in the colon of control mice (Figure 4D), was substantially
increased in the colon of colitic mice, equating to a 12-fold rise
of cfu-GM, with no significant increase in Treg cell protected
mice (Figure 4D). Cell sorting experiments showed that the intes-1120 Immunity 37, 1116–1129, December 14, 2012 ª2012 Elsevier Intinal cfu activity evident in colitis arose from the same rare cellular
subtypes as in the BM, i.e., Lin cells expressing high amounts
of c-Kit (Figure 4E). Other colonic Lin populations, i.e.,
LinSca-1c-Kit and LinSca-1+c-Kit/int cells that are both
predominant in the colon, did not exhibit cfu activity (Figure 4E).
The LSK population that was observed in the inflamed colon
(Figure 4E) did not contain CD150+ LT-HSC, but was CD34+
CD150, correlating with a MPP phenotype (Figure S3B).
These results suggest that the increase of inflammatory
myeloid cells in the colon following colitogenic Th1 and Th17
cell-mediated responses may be partially fueled by colonic
HSPC accumulation. Of particular relevance are highly prolifera-
tive GMPs that contribute to increased cfu activity and by exten-
sion to extramedullary granulomonocytopoiesis during intestinal
inflammation.
Extramedullary Accumulation of GMPs Is Dependent
on Local Tissue Inflammation
Because HSCs and GMPs accumulated in the BM and periphery
during colitis, we tested whether injection of G-CSF would
recapitulate the phenotype observed during colitis. Indeed,
G-CSF promotes granulopoiesis and is also a prototypical mobi-
lizing cytokine, stimulating proliferation of HSCs in the BM and
their release into the blood (Morrison et al., 1997). Treatment
with G-CSF, a cytokine that was increased in colitis (Figure 4C),
was sufficient to promote an increase in LSKs and GMPs in the
BM (Figure 5A). In the spleen, G-CSF induced an accumulation
of recirculating LSKs comparable to colitis, but only a modestc.
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tion of GMPs detected in the colon of G-CSF treated mice and
the cfu-GM activity was as low as in control mice (Figure 5C).
Similarly, treatment with GM-CSF stimulated GMP increase in
the BM but did not induce any colonic GMP accumulation (Fig-
ure S4). These results show that the colonic and splenic accumu-
lation of GMPs accompanying colitis cannot be reproduced by
a simple mobilization protocol and likely requires additional local
tissue inflammatory signals associated with IL-23-driven colitis.
IFN-g Promotes Increased HSC Activity during
IL-23-Driven Colitis
We next investigated which inflammatory cytokines drive the
hematopoietic changes associated with IL-23 dependent intes-
tinal inflammation. IFN-g is a well-known colitogenic cytokine
that is increased in the colon and serum of colitic mice (Powrie
et al., 1994 ; Ahern et al., 2010), and its secretion by pathogenic
Th1 and Th17 cells and ILCs is promoted by IL-23 (Ahern et al.,
2010; Buonocore et al., 2010). Its receptor is not only expressed
by mature immune cells, but also by HSCs, which are directly
responsive to IFN-g stimulation in vitro, as well as in vivo during
both homeostasis and following infection (Baldridge et al.,
2010). In addition to the role of IFN-g in T cell mediated disease,
IL-23 dependent innate colitis induced by H. hepaticus infection
of 129SvEv.Rag2/ mice is inhibited by blockade of IFN-g
(Buonocore et al., 2010). In this innate model of colitis, Gr1+
myeloid cells accumulate in the colon and spleen and drive
intestinal inflammation (Erdman et al., 2009; Maloy et al., 2003).
A similar Gr1+ myeloid cell increase was observed in the BM of
H. hepaticus infected mice (Figure 6A). As we observed in T cell
dependent colitis, erythroid cells and NK cells were decreased
compared to uninfected controls (Figure 6A). At the HSPC level,
there was a significant rise in LSK and LT-HSC numbers in the
BM and spleen (Figures S5A and S5B) and in cfu-GM activity in
the colon and spleen 8 wk after infection (Figure 6A). In this
T cell independent model of colitis, blockade of IFN-g diminished
LSK increases in the BM (Figure 6B) and spleen (Figure 6C), as
well as CD34 LT-HSC and CD150+ LT-HSC increases in the
BM (Figure 6B; data not shown). Similar IFN-g promoting effects
on HSCs were observed in T cell transfer colitis (data not shown)
in which a population of IFN-g producing T cells accumulated not
only in the spleen andcolon (Ahern et al., 2010), but also in theBM
(Figures S6E) where they may have increased HSC numbers
directly. Interestingly, Treg cell protected mice in which HSC
did not accumulate in the BM (Figure 2A) exhibited much lower
numbers of IFN-g+ T cells in BM than colitic mice (Figures S6E).
These data, taken together with previous studies demonstrating
cell-intrinsic IFN-g responsiveness by HSC (Baldridge et al.,
2010), suggest that IFN-gmay exert its pathogenic role in colitis
not only by promoting effector functions inmature leukocytes but
also by boosting the hematopoietic activity at the level of the
primordial HSCs that sustain the increased production of down-
stream and non-self-renewing GMPs.
GM-CSF Promotes Pathogenic Accumulation
of Peripheral GMPs and IL-23 Dependent Colitis
Cytokines that drive myelopoiesis, such as the various CSFs, are
produced by stromal cells (e.g., epithelial cells and fibroblasts)
and by innate and adaptive immune cells. GM-CSF has beenImmshown to be pathogenic in experimental autoimmune encepha-
lomyelitis (EAE) and arthritis models (Hamilton, 2008) although its
mechanism of action is not known. Here we show a clear role for
GM-CSF in HSPC activity and development of colitis. Adminis-
tration of anti-GM-CSF inhibited the peripheral accumulation of
GMPs and attenuated intestinal inflammation in T cell transfer
colitis (Figures 7A and 7B). GMP percentages and total numbers
were significantly decreased in the spleen of T cell transferred
mice injected with anti-GM-CSF compared to mice injected
with an isotype control mAb (Figure 7A). In contrast, GM-CSF
was not essential for the increase of the upstream HSCs in the
spleen and BM (Figure S6A) and therefore regulates HSPC
activity downstream of IFN-g. In the colon, GMPs were also
reduced after anti-GM-CSF treatment, and this was accompa-
nied by decreased numbers of neutrophils and histologic inflam-
mation in the colon (Figure 7B). Intestinal GM-CSF amounts were
substantially increased in colitic mice compared to control and
Il23r/ protected mice (Figures 4C and 7C). Transfer experi-
ments utilizing congenically marked IL-23R+ and IL-23R
T cells in which both populations accumulate in the colon simi-
larly (Ahern et al., 2010) showed increased GM-CSF production
among WT colitogenic Th17 cells (Figure 7C). Further analysis of
IL-17A+GM-CSF+ cells showed the majority coexpressed IFN-g,
were enriched in the colon relative to the spleen, and were
present at higher proportions in IL-23R-expressing cells (Fig-
ure S6C). However, it should be noted that polyfunctional Th17
cells are not the only source of GM-CSF and other T cell and
non-T cell sources were also detectable (Figure S6C; data not
shown). Analysis of the requirement for IL-23 in colitis-
associated changes in extramedullary hematopoiesis showed
a significantly reduced, although not completely absent, accu-
mulation of GMP in the BM and periphery of T cell transferred
Rag1/Il23p19/ mice that developed mild intestinal inflam-
mation (Figure S6D; Hue et al., 2006). Collectively, our results
show that GM-CSF is a key driver of extramedullary accumula-
tion of GMPs in IL-23-dependent intestinal inflammation and
contributes to the pathogenicity of the disease. (Figure S6D).
To assess the contribution of peripheral GMPs to intestinal
inflammation, we transferred splenic GMPs into T cell-restored
Rag1/ mice. Adoptive transfer of splenic GMPs isolated from
colitic mice into Rag1/ mice that had received naive T cells
2 weeks before enhanced disease as indicated by an increased
colitis score and weight loss (Figure 7D). The GMP-mediated
aggravation of colitis correlated with a significant increase of
CD11b+Gr1hi cells in the spleen (data not shown) and colon (Fig-
ure 7D) compared tomice that hadonly received naive T cells and
PBS,whereas percentages of CD4+ T cells were unchanged (Fig-
ure 7D). As anticipated, transfer of peripheral GMPs gave rise to
CD11b+Gr1+ myeloid cells during intestinal inflammation (Fig-
ure S6B). Thus, in addition to contributing to increased granulo-
poiesis in the BM, GMPs also accumulate in the inflamed spleen
and colon, where they play a pathogenic role likely by sustaining
the local accumulation of neutrophils and inflammatory mono-
cytes that is characteristic of IL-23-driven intestinal inflammation.
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Figure 4. GMPs Accumulate in the Inflamed Intestinal Mucosa and Trigger Extramedullary cfu Activity in the Colon
cLPL were prepared from control, colitic, and protected mice. Transferred mice were killed 8 wk after T cell transfer.
(A) Representative CMP, GMP, and MEP staining in cLPL. Percentage and absolute number of colonic GMPs.
(B) Percentages of proliferative cells (Ki-67+) among MEPs and GMPs from cLPL of colitic mice.
(C) G-CSF, GM-CSF, SCF (c-KitL), and IL-23p19 mRNA amounts in total colon homogenate (n = 4). Values are normalized to HPRT and are mean values
(±SEM).
Immunity
Dysregulated Hematopoiesis Promotes Colitis
1122 Immunity 37, 1116–1129, December 14, 2012 ª2012 Elsevier Inc.
Gate : Lin- cells
MP LSK
A Bone marrow
69 1.8
18
13
1.3
5268
Gate : Lin- c-Kithi cells
Control                       Colitic G-CSF treated
Sca-1
c-
K
it
Control                     Colitic G-CSF treated
B
Control                       Colitic G-CSF treated
Gate : Lin- c-Kithi Sca-1- cells
Fc
ˠR
II 
an
d 
III
CD34
Fc
ˠR
II 
an
d 
III
CD34
C Colon
Control G-CSF Colitic
0
20
40
60
80
100
120
p=0.005
p=0.005
-GM  per 106 cells
Colon
39 2.1 40            14 35 10
CMP
MEP
Control                        Colitic G-CSF treated
Gate : Lin- c-Kithi Sca-1- cells
47
17
4122
17
Fc
ˠR
II 
an
d 
III
CD34
56
GMP
31
18
33
Spleen
Control                       Colitic G-CSF treated
Gate : Lin- cellsSca-1
49 2.830 440.5 4.1
c-
K
it
81
3.1
6.8
17
10
1.9
4.4
6287
3.4 5.9
cfu
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C57BL/6.Rag1/ mice were injected daily with G-CSF for 3 days and killed 24 hr after the last G-CSF injection (termed G-CSF treated) and compared with
Rag1/ mice killed 8 wk after CD4+CD45RBhi T cell transfer (colitic) and with untransferred Rag1/ mice (control).
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(C) Representative flow cytometry staining of GMPs in colonic LPL is shown on left (n = 4). Colonic cfu-GM activity is shown on right. Data are representative of
two independent experiments.
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Dysregulated Hematopoiesis Promotes ColitisTreg control in target tissues has been extensively studied.
However, the impact of these dysregulated mature cell
responses on myeloid cell development is poorly understood.
In this study, by investigating the regulation of hematopoiesis
during chronic colitis, we provide evidence that IL-23-driven
intestinal inflammation is accompanied by profound changes in
both the hematopoietic progenitor cell and stem cell compart-
ments and that these can contribute directly to disease patho-
genesis. We further show that inflammatory cytokines IFN-g
and GM-CSF control distinct components of the aberrant hema-(D) Cfu activity from plated cLPL. Representative field from photomicrographs o
cfu-GM among total cLPL (right).
(E) Representative c-Kit and Sca-1 staining gated on Lin cells from BM and cLPL
sorting from BM or cLPL of 5 colitic mice; the various Lin FACS-sorted populat
(A–D) Data are representative of two to three independent experiments.
Immtopoietic response. Thus, IFN-g promoted increased HSC
numbers in the BM, along with extramedullary accumulation of
HSCs in the spleen. By contrast, GM-CSF was involved in the
accumulation of highly proliferative GMPs in the inflamed spleen
and colon and was essential for development of colitis.
Remarkably, the hematopoietic hierarchy was affected by the
ongoing intestinal inflammation as early as its most primordial
stage because LT-HSCswere greatly increased in the BMduring
colitis. HSC proliferation was substantially increased during
colitis and correlated with a sustained differentiation intof Methocult plate with typical images of cfu (magnification 310). Frequency of
of colitic mice (left). Number of cfus from 500 plated Lin cells isolated by cell
ions are identified on the horizontal axis (right).
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Figure 6. IFN-g Promotes Exacerbated HSC Activity during IL-23-Driven Colitis
Innate colitis was induced byH. hepaticus (Hh) infection of 129SvEv Rag2/mice. Mice were killed 8 wk (colitic) in (A) or 2 wk (Hh) in (B) and (C) afterH. hepaticus
feeding and compared to untreated Rag2/ mice (control) or untreated Rag2+/+ mice where indicated.
(A)RepresentativeGr1, Ter119,andNKp46staining in theBM isshownon left. Frequencyof clonogeniccfu-GMamong total splenocytesandcLPL is shownon right.
(B) Infected mice were either injected weekly with anti-IFN-g (Hh + anti-IFN-g) or left untreated (Hh). Flow cytometry analysis and percentages of LSKs in BM
(upper panels). Percentages and absolute numbers of LT-HSCs in BM (lower panels).
(C) FACS analysis, percentages, and absolute numbers of LSKs in spleen.
(A–C) Data are representative of two independent experiments.
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BM. Classically, HSCs are perceived as passive components
of the immune response, replenishing available niches to main-1124 Immunity 37, 1116–1129, December 14, 2012 ª2012 Elsevier Intain immune system homeostasis (Kondo et al., 2003). However,
recent studies in the field of antimicrobial immunity show that
HSC proliferation is directly stimulated by certain inflammatoryc.
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Dysregulated Hematopoiesis Promotes Colitiscytokines and TLR ligands (Takizawa et al., 2012). For example,
IFN-g secretion upon Mycobacterium avium infection directly
increases HSC proliferation and numbers in the BM (Baldridge
et al., 2010). Our observations in colitis show that HSC activation
in response to environmental cues is not solely restricted to anti-
microbial responses but also occurs during noninfectious
chronic inflammatory disease. However, it is important to
highlight that HSC accumulation is not a general feature of
inflammatory immune responses. Indeed, during Plasmodium
chabaudi infection, an atypic myelolymphoid progenitor
emerged in the BM but LT-HSCs were not increased (Belyaev
et al., 2010). Furthermore, autoimmunity in Foxp3/ mice was
associated with decreased marrow LT-HSC numbers during
the course of disease (Chen et al., 2010). Indeed, the nature of
the eliciting immune stimulus appears to shape the hematopoi-
etic response. Thus, contrary to what we observed during colitis,
GMPs were decreased but CLPs were increased in the BM of
M. avium-infected mice (Baldridge et al., 2010). Immunity to
the Trichinella spiralis helminth correlated with substantial accu-
mulation of eosinophil progenitors in the BM of infected mice
(Iwasaki et al., 2005), and the pro-Th2 cell-derived cytokine IL-
25 elicited the specific production of Th2 cell-biased multipotent
progenitors (MPP2) (Saenz et al., 2010). Thus, analogous to the
specialized T helper cell responses that develop according to
the nature of the microbial stimuli, functional specialization
among HSPCs allows the hematopoietic system to mount
a precise response adapted to the specific peripheral challenge.
In addition to profound changes in HSPCs in BM, HSCs and
GMPs accumulated in the spleen during colitis. High numbers
of undifferentiated monocytes reside in the spleen, outnumber-
ing their equivalent in the blood, and these splenic monocytes
rapidly migrate to tissues upon inflammation (Swirski et al.,
2009).Wealso found that the inflamed spleen constitutes a reser-
voir of HSCs and GMPs that might have contributed to the
increase in splenic myeloid cells and could also migrate to the
colon during inflammation. Interestingly, Foxp3/mice develop
a splenomegaly that is accompanied by splenic cfu-GM
increase, and this was inhibited by the infusion of CD25+ Treg
cells at birth (Lee et al., 2009). In our study, protection from colitis
by Treg cells prevented increased HSPC activity in the BM and
periphery. It is possible that in addition to effects on mature
immune cells, Treg cells directly inhibit HSPC activity via
suppressive cytokine secretion. Indeed, key cytokines involved
in Treg-mediated control of colitis have been shown to affect
HSC, TGF-b directly signals to HSCs to restrain their proliferation
(Yamazaki et al., 2009) and a large proportion of HSCs also
express the IL-10R (Kang et al., 2007).
Increased hematopoietic activity in the spleen of colitic mice
was accompanied by an unexpected cfu-GM activity in the
inflamed colon that correlated with GMP accumulation. The
a4b7 was expressed by 10% to 20% of HSPCs, and this colon
homing receptor was increased on BM and splenic HSCs during
colitis (Figure S3C). Its ligand MAdCAM1 is increased during
intestinal inflammation (Souza et al., 1999); thus, HSPCs might
be guided to the inflamed colon as a result of their expression
of a4b7 integrin. At steady state, a rare but reproducible cfu
activity was detectable in the colon in line with previous observa-
tions that a scarce population of recirculating HSPCs constantly
survey nonlymphoid tissues and can trigger local urgent hemato-Immpoiesis upon TLR stimulation (Massberg et al., 2007). This mech-
anism, from which a sizable pool of myeloid cells originated, is
potentially beneficial for the host during microbial infection but
detrimental during chronic inflammation. Indeed, GMPs that
accumulated in inflamed colon were highly proliferative and
may provide a rapid and local source of myeloid cells that
sustains disease. Indeed, adoptive transfer of peripheral GMPs
aggravated ongoing colitis and correlated with increased
CD11b+Gr1+ cells in colon and spleen.
With regard to therapeutic utility, it is clearly of interest to iden-
tify the various inflammatory cytokines produced during colitis
that promote exacerbated HSCproliferation and biased differen-
tiation towardGMPs. HSCs express receptors for IFNs, IL-1, and
IL-6 (Chen et al., 2010; Ueda et al., 2009) and are therefore
poised to respond promptly to various inflammatory stimuli.
Recent studies have identified direct activity of IFN-g on HSC.
Thus, HSCs express high amounts of IFN-g-R and proliferate
in an IFN-gR1- and Stat1-dependent fashion, in response to
M. avium-induced IFN-g secretion (Baldridge et al., 2010).
Control of HSC proliferation by IFN-g also occurs under homeo-
static conditions because injection of recombinant IFN-g
increased proliferation of LT-HSC in normal mice and there
was reduced endogenous HSC proliferation in Ifng/ mice
(Baldridge et al., 2010). In our study, IFN-g blockade, which
ameliorates colitis in both innate and T cell transfer models
(Buonocore et al., 2010; Powrie et al., 1994), significantly
reduced the BM and splenic accumulation of HSCs. In colitic
mice, there was a marked accumulation of IFN-g+ T cells in the
BM where they may directly influence the HSC population. It
was notable that the accumulation of IFN-g+ T cells in BM was
inhibited by Treg cell cotransfer but still occurred in the absence
of IL-23 (Figure S6E). This activity correlates with modest IL-23
independent increases in LSK and GMP in the BM of T cell
restored Il23p19/Rag1 / compared to unmanipulated
controls. This result fits with our previous observations of IL-23
independent systemic inflammation in T cell restored immune-
deficient mice (Hue et al., 2006). These results suggest that
IFN-g may exert its colitogenic activity not only by promoting
the effector arm of the immune system, but also by acting on
the primordial step of the hematopoietic system by increasing
HSC proliferation during colitis. Enhanced activity of the self-re-
newing HSC is probably crucial for the chronicity of increased
myelopoiesis during colitis, because it allows for a sustained
supply of short-lived medullary and peripheral GMPs (Passegue´
et al., 2005). HSC differentiation into various lineage-committed
progenitors is influenced by cytokines acting on HSPCs down-
stream of IFN-g, e.g., the various CSFs. For example, GM-CSF
is thought to drive the HSCs away from CLP development in
favor of CMPs (Kondo et al., 2003) and later promote both prolif-
eration and survival of GMPs (Kimura et al., 2009).
Recently IL-23 dependent secretion of GM-CSF by T helper
cells has been shown to be crucial in experimental allergic
encephalomyelitis (EAE) development (Codarri et al., 2011; El-
Behi et al., 2011). However the downstream effects of GM-CSF
during chronic inflammatory diseases are still unclear. Among
HSPC, GM-CSF-R is expressed by CMPs andGMPs, but absent
from MEPs and CLPs (Takizawa et al., 2012). In colitis, neutrali-
zation of GM-CSF markedly decreased the splenic and colonic
accumulation of GMPs and the severity of intestinal inflammationunity 37, 1116–1129, December 14, 2012 ª2012 Elsevier Inc. 1125
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Figure 7. GM-CSF Promotes Pathogenic Accumulation of Peripheral GMPs and IL-23 Dependent Colitis
(A and B) Rag1/ mice transferred with naive T cells were injected two times per week with either anti-GM-CSF mAb or isotype control, killed 8 wk after T cell
transfer, and compared with untransferred control mice.
(A) Representative staining, frequencies, and absolute numbers of GMPs in the spleen.
(B) Score of colitis and photomicrographs of proximal-colon sections (upper panels). Original magnification 1003. GMP and neutrophil numbers in the cLPL
(lower panels).
(A and B) Data are representative of two independent experiments.
(C) Left shows that Rag1/mice were cotransferred with 1:1 mixtures of CD45.1+ (WT) + CD45.2+ (Il23r/) naive CD4 T cells to assess whether IL-23 has a cell
intrinsic effect on GM-CSF production by Th cells as described in (Ahern et al., 2010). CD45.1+ cells were isolated from congenic B6.SJL-Cd45.1 and CD45.2+
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tions, GM-CSF treatment induced GMP but not HSC increase
in BM and spleen. Therefore, one of the pathogenic roles played
by GM-CSF, which is secreted not only by Th cells but also by
myeloid cells and stromal cells during inflammation (Hamilton,
2008), is to trigger extramedullary hematopoiesis and increase
inflammatory myeloid accumulation in target organs during
chronic inflammatory disease. In addition to promoting myeloid
progenitor activity during colitis, GM-CSF may have additional
effects on mature cells. Indeed, GM-CSF enhances IL-23
production by antigen-presenting cells in vitro (El-Behi et al.,
2011). Those results together with our own suggest a positive
feedback loop in which IL-23 stimulates GM-CSF production
by polyfunctional Th17 cells in the colon, which in turn may act
to further enhance IL-23 production by APC. Cytokine-driven
alterations in hematopoiesis may be a common and somewhat
overlooked pathogenic mechanism. For example, IL-17 has
been reported to stimulate hematopoietic activity in the BM via
stimulation of G-CSF secretion by stromal cells, and in the
spleen via G-CSF dependent and independent mechanisms
(Schwarzenberger et al., 2000).
Collectively, our results shed light on the selectivity and
complexity of cytokine-mediated regulation of HSPC activity
during IL-23-driven chronic inflammation. They support a ‘‘two
hit’’ model for aberrant intra- and extramedullary myelopoiesis
in colitis as follows: (1) IFN-g-dependent increased HSC activity
followed by (2) GM-CSF-dependent increased HSC differentia-
tion into highly proliferative GMPs. Ultimately, we believe that
precisely dissecting the cytokines and microbial signals that
control HSPC function will offer opportunities to develop novel
therapeutics in IBD and other chronic inflammatory diseases
with a strong myeloid component (e.g., rheumatoid arthritis)
and will also improve our general understanding of the regulation
of hematopoiesis.
EXPERIMENTAL PROCEDURES
Mice
Wild-type C57BL/6, congenic B6.SJL-Cd45.1, C57BL/6.Rag1/, C57BL/
6.Rag1/Il23p19/, C57BL/6.Il23r/, 129SvEv, and 129SvEv.Rag2/
mice were bred and maintained under specific pathogen–free conditions in
accredited animal facilities at the University of Oxford. Where indicated,
mice were intraperitoneally (i.p.) injected with recombinant hG-CSF (5 mg /
injection; CSL Ltd) or mGM-CSF (5 mg/injection; Peprotech) for three consec-
utive days and were killed 24 hr after the last injection. All procedures involving
animals were conducted according to the requirements and with the approval
of the UK Home Office Animals (Scientific Procedures) Acts, 1986. Mice were
negative for Helicobacter spp. and other known intestinal pathogens and were
8–12 weeks old when first used.
Induction of Colitis
For the T cell transfermodel of colitis, naive CD4+CD25CD45RBhi T cells were
FACS-sorted from C57BL/6 mice, as described previously (Izcue et al., 2008)cells from Il23r/ mice. Mice were killed 4 wk after T cell transfer and percenta
intracellular flow cytometry. Right shows that WT and Il23r/ C57BL/6 mice we
when colitic (week 2) and compared with Il23r/ protected mice and unmanipu
(D) Rag1/mice that had received naive T cells (‘‘RBhi’’) 14 days before were inj
indicated. GMPs and MEPs were sorted from the spleen of colitic mice (8 wk po
GMPs, orMEPs injection and frequencies of neutrophils and CD4+ T cells in cLPL.
is pooled from two independent experiments. Error bars represent SEM.
Immand injected i.p. into C57BL/6.Rag1/ recipients (43 105/mouse). Protective
CD4+CD45RBloCD25+ Treg cells (2 3 105/mouse) were coinjected i.p. where
indicated. Any mice losing >20% of their starting body weight or showing
severe signs of disease were killed. Where indicated, mice were i.p. injected
two times per week with 0.25 mg of anti-GM-CSF (MP1-22E9; CSL Ltd) or
isotype control (GL117, rat IgG2a), starting from the first day of the T cell
transfer. Induction of colitis in H. hepaticus dependent models is detailed in
the Supplemental Experimental Procedures.
Histological Assessment of Intestinal Inflammation
Proximal, mid-, and distal colon samples were fixed in buffered 10% formalin
solution. Paraffin embedded sections were cut (5 mm) and stained with hema-
toxylin and eosin, and inflammation was scored in a blinded fashion using
a previously described scoring system (Izcue et al., 2008).
Isolation of Leukocyte Subpopulations and Flow Cytometry
Single cell suspensions were prepared from spleen, MLN, and cLPL as
previously described (Uhlig et al., 2006). BM cell suspensions were prepared
by flushing the marrow out of femur and tibia and were resuspended in
PBS with 2% BSA. Monoclonal antibodies used for flow cytometry analysis
of mature leukocytes and HSPCs are detailed in the Supplemental Experi-
mental Procedures.
Colony Forming Assay
ACK lysed splenocytes (13 105 cells), cLPL (33 105 cells), or flow cytometry-
purified LSK or LinSca-1cKithi cells (500 cells) were suspended inmethylcel-
lulose medium to quantify clonogenic colony forming units in triplicate cultures
(MethoCult GF M3434, Stem Cell Technologies). This medium contains IL-3,
IL-6, and SCF but is G-CSF- and GM-CSF-free. Morphologic analysis of
colony formation was performed after 10–14 days of incubation at 37C using
an inverted microscope. cfu-G (granulocyte), M (macrophage), or GM (granu-
locyte-macrophage) colonies are referred as ‘‘cfu-GM.’’
Quantitation of Gene Expression by Using Real-Time PCR
After homogenization of frozen colonic samples, total tissue RNA was purified
using RNAeasy kits (QIAGEN), and quantitative PCR were performed as
described in the Supplemental Experimental Procedures.
Statistical Analysis
Statistical analysis was performed with Prism 5.0 (GraphPad Software). The
nonparametric Mann-Whitney test was used for all statistical comparisons.
Differences were considered statistically significant when p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at http://dx.doi.org/
10.1016/j.immuni.2012.08.025.
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